34 RSV Hospitalizations

368 hospitalizations

3 deaths

17.4% of cases required ICU care

29.9 hosps per 100,000 population

34.1 Epidemiologic Review

34.1.1 Disease Information

Overview: Respiratory Syncytial Virus (RSV) is a common respiratory virus that generally causes mild symptoms. However, it can cause severe illness in young children and older adults. RSV is the leading cause of hospitalizations in infants in the United States.

Symptoms: RSV usually causes mild cold-like symptoms such as runny nose, congestion, coughing, fever, and wheezing. However, more severe symptoms can develop and cause pneumonia and bronchiolitis.

Transmission: RSV is spread by droplets from a sneeze or cough that contain the virus and enter your nose, eyes, or mouth. Someone may also be infected if they touch a surface that has RSV on it, then touch their face.

Treatment: Most treatment for RSV is symptom based, but an antiviral medication called Ribavirin is available for treatment of severe illness.

Prevention The spread of RSV can be reduced by staying home when you are sick, wearing a mask, and practicing good hand hygiene. For the first time in 2023, a vaccine for RSV was made available for pregnant women, and those over 60 years of age. Two monoclonal antibody injections are also available for children who meet the criteria to receive them.

34.1.2 Demographics

Race	Rate per 100k
American Indian or Alaska Native, Non Hispanic	13.1
Asian, Non Hispanic	14.2
Black or African American, Non Hispanic	29.1
Hispanic or Latino	44.2
Native Hawaiian or Other Pacific Islander, Non Hispanic	99.1
Unknown	<5 cases
White, Non Hispanic	23

34.1.3 Outbreaks

There were no reported outbreaks in 2023.

34.1.4 Monthly and Historical Comparisons

34.2 Key Things to Know

Cardiovascular disease (23%), chronic lung disease (20%), excluding asthma/reactive airway disease, and chronic metabolic disease (16%), were the most common underlying medical conditions in RSV hospitalizations.

Cough, fever, congestion, and shortness of breath were the most commonly reported symptoms by hospitalized RSV cases.

18% of cases were admitted to the intensive care unit.

40% of cases required supplemental oxygen while hospitalized.

55% of cases were diagnosed with bronchiolitis during their hospitalization.